1. Home
  2. CDNA vs VYX Comparison

CDNA vs VYX Comparison

Compare CDNA & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • VYX
  • Stock Information
  • Founded
  • CDNA 1998
  • VYX 1881
  • Country
  • CDNA United States
  • VYX United States
  • Employees
  • CDNA N/A
  • VYX N/A
  • Industry
  • CDNA Medical Specialities
  • VYX
  • Sector
  • CDNA Health Care
  • VYX
  • Exchange
  • CDNA Nasdaq
  • VYX Nasdaq
  • Market Cap
  • CDNA 1.0B
  • VYX 1.1B
  • IPO Year
  • CDNA 2014
  • VYX N/A
  • Fundamental
  • Price
  • CDNA $15.00
  • VYX $8.90
  • Analyst Decision
  • CDNA Buy
  • VYX Strong Buy
  • Analyst Count
  • CDNA 8
  • VYX 6
  • Target Price
  • CDNA $28.14
  • VYX $15.17
  • AVG Volume (30 Days)
  • CDNA 940.1K
  • VYX 2.2M
  • Earning Date
  • CDNA 04-30-2025
  • VYX 05-08-2025
  • Dividend Yield
  • CDNA N/A
  • VYX N/A
  • EPS Growth
  • CDNA N/A
  • VYX N/A
  • EPS
  • CDNA 1.07
  • VYX 6.52
  • Revenue
  • CDNA $346,421,000.00
  • VYX $2,826,000,000.00
  • Revenue This Year
  • CDNA $13.28
  • VYX N/A
  • Revenue Next Year
  • CDNA $15.13
  • VYX N/A
  • P/E Ratio
  • CDNA $13.96
  • VYX $1.30
  • Revenue Growth
  • CDNA 25.92
  • VYX N/A
  • 52 Week Low
  • CDNA $7.42
  • VYX $7.55
  • 52 Week High
  • CDNA $34.84
  • VYX $15.34
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 31.37
  • VYX 50.64
  • Support Level
  • CDNA $14.86
  • VYX $8.36
  • Resistance Level
  • CDNA $18.71
  • VYX $8.48
  • Average True Range (ATR)
  • CDNA 0.98
  • VYX 0.29
  • MACD
  • CDNA -0.24
  • VYX 0.18
  • Stochastic Oscillator
  • CDNA 3.08
  • VYX 91.22

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

Share on Social Networks: